Steroid Induced Modulation of Extracellular Matrix
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
July 01, 2015 - June 30, 2018
Grant ID
G2015078
Summary
Steroids, routinely used to control inflammation, can cause increases in intraocular pressure and threaten a loss of vision in 30-40 percent of all treated individuals. What causes such increases in pressure, and why only a subset of individuals respond adversely to steroids, is not known. We believe that such increases in pressure are due to dysregulation in cellular function and secretion of proteins due to structural alterations to the tissue that is in close proximity with these affected cells. In the proposed study, we will determine whether treatment with steroids alters cellular and matrix structure, composition, biomechanical attributes, and function.
Related Grants
National Glaucoma Research
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine